Efficacy of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience

被引：0
|
作者：
Rocha, F. [1 ]
Stocchi, F. [2 ]
Lees, A. [3 ]
Ferreira, J. [4 ]
Poewe, W. [5 ]
Rascol, O. [6 ]
Santos, A. [7 ]
Magalhaes, D. [1 ]
Soares-da-Silva, P. [7 ]
机构：
[1] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[2] IRCCS San Raffaele, Dept Neurol, Rome, Portugal
[3] Natl Hosp Neurol & Neurosurg, Dept Neurol, London, England
[4] Univ Lisbon, Dept Neurol, Fac Med, Lisbon, Portugal
[5] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[6] Univ Hosp Toulouse, Dept Neurol, Toulouse, France
[7] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2019年 / 405卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
10.1016/j.jns.2019.10.1151
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WCN19-0301
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Opicapone's efficacy in Parkinson's disease patients with motor fluctuations: a phase III, randomized, double-blind, placebo and active-controlled study - bipark I study
    Ferreira, J.
    Lees, A.
    Rocha, I.
    Santos, A.
    Lopes, N.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E284 - E285
  • [22] Management of dyskinesia in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience
    Pagonabarraga, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 516 - 516
  • [23] Dyskinesia management in COMT-naive patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience
    Pagonabarraga, J.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Arbe, E.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S103 - S103
  • [24] Association of patient global impression of change and other endpoints of efficacy in Parkinson's disease patients: a post-hoc analysis from combined BIPARK-I and II data
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Costa, R.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 467 - 467
  • [25] Relationship between Patient Global Impression of Change and other Efficacy Endpoints in Parkinson's Disease: A post-hoc analysis from combined BIPARK-I and II
    Ferreira, J.
    Poewe, W.
    Rascol, O.
    Costa, R.
    Arbe, E.
    Rocha, J-F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2018, 33 : S118 - S118
  • [26] Efficacy and safety of opicapone in patients with Parkinson's disease and motor fluctuations: 1-year follow-up (bipark I)
    Ferreira, J.
    Lees, A.
    Rocha, I.
    Santos, A.
    Lopes, N.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E285 - E285
  • [27] Dopaminergic adverse-events in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience
    Chaudhuri, K. Ray
    Sauerbier, A.
    Ferreira, J.
    Stocchi, F.
    Arbe, E.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 247 - 247
  • [28] The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
    Rocha, Jose-Francisco
    Ebersbach, Georg
    Lees, Andrew
    Tolosa, Eduardo
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Magalhaes, Diogo
    Gama, Helena
    Soares-da-Silva, Patricio
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [29] The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
    Rocha, Jose-Francisco
    Ebersbach, Georg
    Lees, Andrew
    Tolosa, Eduardo
    Ferreira, Joaquim J.
    Poewe, Werner
    Rascol, Olivier
    Stocchi, Fabrizio
    Antonini, Angelo
    Magalhaes, Diogo
    Gama, Helena
    Soares-da-Silva, Patricio
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [30] Influence of disease severity in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Gama, H.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Antonini, A.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S41 - S41
12345